Countdown to IAS Pharma2024
  • days
  • hours
  • minutes
  • seconds
  • IAS Pharma2024
    Day 3
    Dr Steven Okoli
    Dr Steven Okoli

    Adult Stem Cell Transplant Lead for Sickle Cell Disease,
    Imperial College NHS Trust

    Dr Okoli completed his haematology training in South West London, based mainly at Guy’s & St Thomas’ Hospitals. He then embarked on a Research Fellowship in rare anaemias at the Weatherall Institute, Oxford, in an international project to describe and understand unexplained non-spherocytic haemolytic anaemias.

    Following this, Dr Okoli undertook several posts as a red cell haematology consultant at large teaching hospitals in South London. In 2016, he joined Imperial College as a clinical research fellow. In this role, he completed a PhD investigating the epigenetic mechanism by which HDAC inhibitors could be used to treat G6PD deficiency.

    On completion of his PhD, Dr Okoli was appointed to his current roles as an honorary senior clinical lecturer, at Imperial College, and consultant Haematologist, at Imperial College Healthcare NHS Trust. His main areas of practice are in sickle cell disease, thalassaemia and rare anaemias. He is the sub-specialty lead for the North West London NIHR Clinical Research Network, and is principal investigator for several clinical studies including: the NIHR BioResource Research Tissue Bank – Improving Black Health Outcomes, Study of Genomic Integrity and Safety of Stem-cell Gene Therapy in Sickle Cell Disease funded by the Gates Foundation, INHERENT (an international collaboration that aims to identify genetic modifiers of haemoglobinopathies), and several early phase clinical trials of novel therapies in the treatment of sickle cell disease. He is also the adult stem cell transplant lead for sickle cell disease at Imperial College NHS Trust.

    Dr Okoli has a particular interest in education and, in his role as an honorary clinical lecturer, he teaches on the Haematology BSc course based at Imperial College. His other activities include his role as a Medical Advisor for the African Caribbean Leukaemia Trust.

    Our Partners and Sponsors

    Meet our Partners and Sponsors who are helping us champion effective advocacy in Africa clinical trials. To become an IAS Partner or Sponsor, please click the button below.

    Become an IAS Pharma Sponsor

    Get regular updates and hear the latest news and advancements from our team. Sign up for email updates.

    The IAS PHARMA 2024 is organized by Xcene Research, an African Contract Research Organization committed to providing clinical trials access to a more diverse population in Africa.

    Xcene Research Corporate Office

    1 Ogunsiji Close, S&B Tejuosho Estate, Allen Avenue Ikeja, Lagos Nigeria

    Connect With Us

    ©2025, Xcene Research. All Rights Reserved.